XML 35 R23.htm IDEA: XBRL DOCUMENT v3.24.3
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2024
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES  
Schedule of inventory

 

 

September 30,

2024

 

 

December 31,

2023

 

Raw Goods

 

$5,704,069

 

 

$4,962,652

 

Finished Goods

 

 

4,044,868

 

 

 

5,212,015

 

Total Inventory

 

$9,748,937

 

 

$10,174,667

 

Schedule of disaggregation of revenue

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

Type of Sale

 

2024

 

 

 

 

 

2023

 

 

 

 

 

2024

 

 

 

 

 

2023

 

 

 

 

Net sales of raw materials to customers

 

$96,208

 

 

 

1%

 

$618

 

 

 

0%

 

$856,457

 

 

 

3%

 

$3,696

 

 

 

0%

Net sales of products to private label clients

 

 

784,352

 

 

 

9%

 

312,905

 

 

 

2%

 

2,868,515

 

 

 

10%

 

1,178,686

 

 

 

3%

Net sales of products to wholesalers

 

 

2,300,720

 

 

 

26%

 

2,535,597

 

 

 

19%

 

7,525,399

 

 

 

26%

 

7,437,453

 

 

 

20%

Net sales of products to distributors

 

 

4,660,483

 

 

 

54%

 

9,640,568

 

 

 

74%

 

15,031,446

 

 

 

52%

 

27,738,487

 

 

 

73%

Net sales of products to end consumers

 

 

849,913

 

 

 

10%

 

616,592

 

 

 

5%

 

2,563,806

 

 

 

9%

 

1,732,293

 

 

 

5%

Net Sales

 

$8,691,675

 

 

 

100%

 

$13,106,280

 

 

 

100%

 

$28,845,623

 

 

 

100%

 

$

38,090,615

 

 

 

100%

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

Product Type

 

2024

 

 

 

 

2023

 

 

 

 

2024

 

 

 

 

2023

 

 

 

 

Vapes

 

$3,381,277

 

 

 

39%

 

$7,405,541

 

 

 

57%

 

$13,509,201

 

 

 

47%

 

$19,846,178

 

 

 

52%

Edibles

 

 

4,074,937

 

 

 

47%

 

 

3,293,422

 

 

 

25%

 

 

11,423,876

 

 

 

40%

 

 

10,849,438

 

 

 

28%

Flower

 

 

253,832

 

 

 

3%

 

 

1,165,926

 

 

 

9%

 

 

1,255,326

 

 

 

4%

 

 

4,203,894

 

 

 

11%

Cartridges

 

 

944,639

 

 

 

11%

 

 

1,223,320

 

 

 

9%

 

 

2,523,090

 

 

 

9%

 

 

3,165,575

 

 

 

8%

Apparel and Accessories

 

 

36,989

 

 

 

0%

 

 

18,071

 

 

 

0%

 

 

134,128

 

 

 

0%

 

 

25,530

 

 

 

0%

Net Sales

 

$8,691,675

 

 

 

100%

 

$13,106,280

 

 

 

100%

 

$28,845,623

 

 

 

100%

 

$38,090,615

 

 

 

100%

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

Hemp vs Non-Hemp Product Sales

 

2024

 

 

 

 

 

2023

 

 

 

 

 

2024

 

 

 

 

 

2023

 

 

 

 

Net sales of hemp products

 

$8,416,929

 

 

 

97%

 

$12,957,460

 

 

 

99%

 

$28,022,767

 

 

 

97%

 

$35,587,865

 

 

 

93%

Net sales of non-hemp products

 

274,746

 

 

 

3%

 

148,820

 

 

 

1%

 

 

822,855

 

 

 

3%

 

2,502,750

 

 

 

7%

Net Sales

 

$8,691,675

 

 

 

100%

 

$13,106,280

 

 

 

100%

 

$28,845,623

 

 

 

100%

 

$38,090,615

 

 

 

100%

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

Location of Sale

 

2024

 

 

 

 

 

2023

 

 

 

 

 

2024

 

 

 

 

 

2023

 

 

 

 

Inside of USA

 

$8,691,675

 

 

 

100%

 

$13,096,973

 

 

 

100%

 

$28,845,623

 

 

 

100%

 

$38,056,082

 

 

 

100%

Outside of USA

 

-

 

 

 

0%

 

 

9,307

 

 

 

0%

 

 

-

 

 

 

0%

 

34,533

 

 

 

0%

Net Sales

 

$8,691,675

 

 

 

100%

 

$13,106,280

 

 

 

100%

 

$28,845,623

 

 

 

100%

 

$38,090,615

 

 

 

100%
Schedule of deferred revenue

 

 

September 30,

2024

 

 

December 31,

2023

 

Contract Assets (invoiced but unfulfilled performance obligations)

 

$552,840

 

 

$131,304

 

 

 

 

 

 

 

 

 

 

Deposits from customers for unfulfilled orders

 

 

469,400

 

 

 

104,586

 

 

 

 

 

 

 

 

 

 

Total Deferred Revenue

 

$1,022,241

 

 

$235,891

 

Schedule of Earnings Per Share, Basic and Diluted

 

 

For the Three Months Ended

 

 

 

 

For the Nine Months Ended

 

 

 

September 30,

 

 

 

 

September 30,

 

 

 

2024

 

 

2023

 

 

 

 

2024

 

 

2023

 

Net Income/(Loss)

 

$(194,399)

 

$617,648

 

 

Net Income/(Loss)

 

$(1,858,615)

 

$2,135,367

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

14,822,678

 

 

 

14,648,874

 

 

Basic

 

 

14,795,977

 

 

 

14,470,895

 

Diluted

 

 

14,822,678

 

 

 

15,356,374

 

 

Diluted

 

 

14,795,977

 

 

 

15,178,395

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic Net Income/(Loss) per Common Share

 

$(0.01)

 

$0.04

 

 

Basic Net Income/(Loss) per Common Share

 

$(0.13)

 

$0.15

 

Diluted Net Income/(Loss) per Common Share

 

$(0.01)

 

$0.04

 

 

Diluted Net Income/(Loss) per Common Share

 

$(0.13)

 

$0.14